IDH2 and melanoma: To confirm the antitumor effects of (R)-2-HG and (S)-2-HG in vivo, mice implanted with subcutaneous tumors that are wild type for IDH2 (U87MG, human colorectal HCT116 and murine B16 melanoma) received multiple treatments of each enantiomer.